The University of Chicago Header Logo

Jessica Donington

Concepts (425)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
60
2025
1136
13.570
Why?
Lung Neoplasms
86
2025
2390
12.750
Why?
Pneumonectomy
26
2025
215
6.410
Why?
Neoplasm Staging
42
2025
2025
3.520
Why?
Thoracic Surgery
9
2025
49
3.210
Why?
Surgeons
6
2022
254
1.940
Why?
Neoplasm Recurrence, Local
13
2024
1378
1.880
Why?
Osteopontin
6
2013
47
1.850
Why?
Thoracic Surgical Procedures
5
2024
56
1.670
Why?
Neoadjuvant Therapy
9
2024
396
1.640
Why?
Radiosurgery
9
2021
287
1.630
Why?
Humans
143
2025
91302
1.500
Why?
Physicians, Women
5
2022
59
1.490
Why?
Early Detection of Cancer
6
2025
428
1.470
Why?
Specialties, Surgical
2
2021
70
1.340
Why?
Thoracic Surgery, Video-Assisted
6
2022
33
1.280
Why?
Mesothelioma
14
2023
327
1.210
Why?
Adenocarcinoma
11
2016
1185
1.200
Why?
Pleural Neoplasms
11
2016
204
1.090
Why?
Small Cell Lung Carcinoma
4
2023
118
1.030
Why?
Esophagectomy
5
2009
91
1.020
Why?
Societies, Medical
7
2025
599
0.940
Why?
Disease Management
3
2019
337
0.830
Why?
Chemotherapy, Adjuvant
6
2022
479
0.820
Why?
Catheter Ablation
6
2015
257
0.810
Why?
Thymectomy
1
2022
31
0.810
Why?
Jehovah's Witnesses
1
2022
21
0.800
Why?
Mass Screening
4
2025
646
0.800
Why?
Tomography, X-Ray Computed
11
2020
2716
0.790
Why?
Immunotherapy
6
2023
705
0.770
Why?
Myasthenia Gravis
1
2022
83
0.770
Why?
Radium
4
2023
7
0.770
Why?
Biomarkers, Tumor
5
2021
1563
0.740
Why?
United States
19
2025
7214
0.710
Why?
Symptom Assessment
1
2020
67
0.690
Why?
Antibody Formation
1
2020
174
0.680
Why?
Treatment Outcome
15
2024
8466
0.680
Why?
Esophageal Neoplasms
4
2009
333
0.680
Why?
Antibodies, Viral
2
2021
313
0.660
Why?
Female
51
2025
47302
0.660
Why?
Combined Modality Therapy
11
2022
1716
0.660
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
2552
0.650
Why?
Surgical Flaps
3
2017
254
0.650
Why?
Male
46
2025
43394
0.630
Why?
Aged
32
2024
19622
0.630
Why?
Carcinoma, Squamous Cell
5
2016
1095
0.620
Why?
Neoplasms, Second Primary
5
2016
241
0.600
Why?
SEER Program
4
2024
202
0.600
Why?
Middle Aged
36
2024
26639
0.590
Why?
Robotic Surgical Procedures
2
2022
337
0.590
Why?
Retrospective Studies
16
2024
9427
0.540
Why?
Probability
1
2017
356
0.540
Why?
Salvage Therapy
2
2017
234
0.540
Why?
Skin Ulcer
1
2016
25
0.540
Why?
Hyaluronan Receptors
2
2013
38
0.510
Why?
Frozen Sections
1
2015
49
0.500
Why?
Skin Transplantation
1
2016
187
0.490
Why?
Prognosis
16
2021
3828
0.490
Why?
Monitoring, Intraoperative
1
2015
109
0.480
Why?
Esophagus
2
2006
107
0.480
Why?
Fluorodeoxyglucose F18
3
2012
143
0.450
Why?
Pancoast Syndrome
1
2013
2
0.440
Why?
Survival Rate
10
2024
1901
0.440
Why?
Radiation Injuries
3
2024
159
0.440
Why?
Radiopharmaceuticals
3
2012
198
0.440
Why?
Fas Ligand Protein
1
2013
49
0.420
Why?
Adult
28
2024
27222
0.410
Why?
Positron-Emission Tomography
5
2013
343
0.410
Why?
Fluorine Radioisotopes
1
2012
25
0.380
Why?
Cyclooxygenase 2
1
2012
99
0.380
Why?
Aged, 80 and over
16
2023
6855
0.380
Why?
Skin Neoplasms
1
2016
605
0.370
Why?
Neurosurgical Procedures
1
2013
245
0.360
Why?
Multimodal Imaging
1
2012
116
0.360
Why?
Thoracic Neoplasms
2
2024
66
0.360
Why?
Bronchogenic Cyst
1
2010
5
0.360
Why?
Thoracic Diseases
1
2010
27
0.350
Why?
Soft Tissue Infections
1
2010
26
0.350
Why?
Thoracic Wall
1
2010
24
0.350
Why?
Clinical Trials as Topic
4
2020
1144
0.350
Why?
Survival Analysis
4
2019
1501
0.330
Why?
Risk Assessment
7
2022
2346
0.330
Why?
Cost-Benefit Analysis
2
2024
481
0.330
Why?
Radiotherapy, Adjuvant
3
2022
291
0.330
Why?
Simulation Training
2
2021
105
0.320
Why?
Education, Medical, Graduate
3
2020
407
0.320
Why?
Lung Transplantation
2
2024
344
0.300
Why?
Health Status Disparities
1
2011
193
0.300
Why?
Neoplasm Proteins
1
2012
541
0.300
Why?
Perfusion
3
2024
255
0.300
Why?
Consensus
4
2024
376
0.270
Why?
Dumping Syndrome
1
2006
5
0.260
Why?
Gastric Emptying
1
2006
25
0.260
Why?
Antineoplastic Agents
5
2020
2352
0.260
Why?
Protein Kinase Inhibitors
2
2022
591
0.260
Why?
Healthcare Disparities
1
2011
433
0.250
Why?
Stomach
1
2006
111
0.240
Why?
Esophageal Diseases
1
2005
27
0.240
Why?
Pneumonia, Viral
2
2020
325
0.240
Why?
Patient Selection
3
2020
685
0.240
Why?
Coronavirus Infections
2
2020
310
0.240
Why?
Transcription Factors
1
2013
1672
0.240
Why?
Patient Care Management
2
2020
30
0.240
Why?
Career Mobility
1
2025
37
0.230
Why?
Wounds, Nonpenetrating
1
2006
114
0.230
Why?
Lung
5
2024
1326
0.230
Why?
Computer Simulation
3
2021
1106
0.230
Why?
Intubation, Intratracheal
1
2006
150
0.230
Why?
Deglutition Disorders
1
2006
120
0.230
Why?
General Surgery
1
2007
241
0.230
Why?
Chemoradiotherapy
3
2024
318
0.230
Why?
Risk Factors
5
2022
5622
0.220
Why?
Chemoradiotherapy, Adjuvant
1
2024
36
0.220
Why?
Gastroesophageal Reflux
1
2006
126
0.220
Why?
Follow-Up Studies
5
2024
3724
0.220
Why?
Postoperative Complications
4
2024
2352
0.220
Why?
Smoking
2
2024
630
0.220
Why?
Medicare
2
2024
432
0.210
Why?
Thymoma
1
2023
31
0.210
Why?
Hamartoma
1
2003
35
0.210
Why?
Kaplan-Meier Estimate
2
2024
855
0.210
Why?
Lymphatic Metastasis
4
2010
500
0.210
Why?
Antibodies, Neutralizing
2
2021
125
0.210
Why?
Negative-Pressure Wound Therapy
2
2014
10
0.210
Why?
Thymus Neoplasms
1
2023
44
0.210
Why?
Medical Oncology
1
2007
390
0.210
Why?
Radiotherapy, Conformal
1
2023
85
0.200
Why?
Carcinoma, Bronchogenic
1
2002
30
0.200
Why?
Chylothorax
1
2022
10
0.200
Why?
Faculty, Medical
1
2025
195
0.200
Why?
Chylous Ascites
1
2022
9
0.200
Why?
Frailty
1
2024
84
0.200
Why?
Time Factors
4
2023
5394
0.190
Why?
Health Care Costs
1
2023
238
0.190
Why?
Neoplasm Metastasis
3
2019
1070
0.190
Why?
ErbB Receptors
2
2022
500
0.190
Why?
Steroids
1
2022
173
0.190
Why?
Loss of Function Mutation
1
2021
47
0.190
Why?
Funnel Chest
1
2021
9
0.180
Why?
Pneumothorax
2
2020
53
0.180
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
105
0.180
Why?
Lung Diseases
1
2003
279
0.180
Why?
Cohort Studies
6
2024
2909
0.180
Why?
Spike Glycoprotein, Coronavirus
1
2021
45
0.180
Why?
Immunization, Passive
1
2020
71
0.180
Why?
Betacoronavirus
2
2020
266
0.170
Why?
Critical Pathways
1
2020
37
0.170
Why?
Pandemics
3
2021
795
0.170
Why?
Case-Control Studies
4
2013
1884
0.170
Why?
Sexual Harassment
1
2019
9
0.160
Why?
Career Choice
1
2021
150
0.160
Why?
Clinical Decision-Making
2
2019
283
0.160
Why?
Protein Isoforms
2
2010
281
0.160
Why?
Nontuberculous Mycobacteria
1
2018
10
0.160
Why?
Sexism
1
2019
55
0.160
Why?
Drainage
1
2020
169
0.160
Why?
Randomized Controlled Trials as Topic
2
2020
866
0.160
Why?
Mycobacterium Infections, Nontuberculous
1
2018
28
0.150
Why?
Immunoglobulin G
1
2020
477
0.150
Why?
Diagnosis, Differential
4
2013
1611
0.150
Why?
Periodicals as Topic
1
2020
168
0.150
Why?
Thoracotomy
1
2018
64
0.150
Why?
Respiratory System
1
2018
119
0.150
Why?
Drug Resistance, Neoplasm
1
2021
616
0.140
Why?
Safety-net Providers
1
2018
37
0.140
Why?
Wound Closure Techniques
1
2017
15
0.140
Why?
Consolidation Chemotherapy
1
2017
23
0.140
Why?
Evidence-Based Medicine
2
2017
443
0.140
Why?
Prosthesis-Related Infections
1
2017
61
0.140
Why?
Lymph Nodes
2
2011
554
0.130
Why?
Meta-Analysis as Topic
4
2016
82
0.130
Why?
Cell Proliferation
2
2013
1695
0.130
Why?
Asbestos
2
2012
22
0.120
Why?
National Cancer Institute (U.S.)
1
2015
72
0.120
Why?
Apoptosis
2
2013
1725
0.120
Why?
Defibrillators, Implantable
1
2017
147
0.120
Why?
Forecasting
1
2016
308
0.120
Why?
Biopsy
2
2016
1197
0.120
Why?
Surgical Wound Infection
1
2017
205
0.120
Why?
Subcutaneous Emphysema
1
2014
8
0.120
Why?
Photochemotherapy
1
1995
100
0.120
Why?
Liver Transplantation
1
2022
1182
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2013
888
0.120
Why?
Simian virus 40
4
1998
35
0.120
Why?
Area Under Curve
2
2012
338
0.110
Why?
Radiography
2
2014
810
0.110
Why?
Prospective Studies
6
2023
4375
0.110
Why?
Receptor, EphB2
1
2013
3
0.110
Why?
Neoplasm Invasiveness
2
2013
572
0.110
Why?
Peritoneum
1
2013
57
0.110
Why?
Snail Family Transcription Factors
1
2013
47
0.110
Why?
Neoplasm, Residual
2
2019
185
0.100
Why?
Clinical Protocols
1
2013
158
0.100
Why?
Microbiota
1
2018
411
0.100
Why?
Operative Time
1
2013
151
0.100
Why?
Surveys and Questionnaires
1
2021
2699
0.100
Why?
Blotting, Western
2
2013
795
0.100
Why?
ROC Curve
2
2012
786
0.100
Why?
Epithelium
1
2013
324
0.100
Why?
Organ Preservation
2
2024
130
0.100
Why?
Clinical Trials, Phase III as Topic
2
2007
169
0.100
Why?
Extracellular Matrix Proteins
1
2012
128
0.100
Why?
Pain Management
1
2013
146
0.100
Why?
Cytokines
3
2022
824
0.100
Why?
Solitary Pulmonary Nodule
1
2013
138
0.100
Why?
Time-to-Treatment
1
2013
126
0.100
Why?
Biomarkers
2
2016
1824
0.100
Why?
Job Satisfaction
1
2012
79
0.090
Why?
Palliative Care
1
2013
264
0.090
Why?
Occupational Exposure
1
2012
88
0.090
Why?
Radiotherapy, Computer-Assisted
1
2011
24
0.090
Why?
Young Adult
5
2021
6527
0.090
Why?
Carcinoma, Large Cell
1
2011
39
0.090
Why?
Sternoclavicular Joint
1
2010
2
0.090
Why?
Pulmonary Surgical Procedures
1
2010
8
0.090
Why?
Colony-Forming Units Assay
1
2010
41
0.090
Why?
Antibodies, Monoclonal
1
2017
1404
0.090
Why?
Cranial Irradiation
2
2020
40
0.090
Why?
Cell Movement
2
2013
793
0.090
Why?
Ribonucleases
1
2011
93
0.090
Why?
Oligonucleotide Array Sequence Analysis
2
2010
694
0.090
Why?
Computer-Assisted Instruction
1
2011
44
0.090
Why?
Debridement
1
2010
61
0.090
Why?
Models, Anatomic
1
2011
92
0.090
Why?
Functional Laterality
1
2011
199
0.090
Why?
Tumor Cells, Cultured
3
2009
1049
0.090
Why?
Mutation
1
2022
4210
0.090
Why?
Models, Cardiovascular
1
2011
107
0.090
Why?
Joint Diseases
1
2010
49
0.090
Why?
Tumor Burden
2
2011
317
0.090
Why?
Cell Line, Tumor
3
2011
2627
0.090
Why?
Necrosis
1
2010
211
0.090
Why?
Epithelial-Mesenchymal Transition
1
2010
100
0.080
Why?
Tracheal Neoplasms
1
2009
8
0.080
Why?
Internship and Residency
1
2019
1073
0.080
Why?
Pain, Postoperative
1
2012
259
0.080
Why?
Glomus Tumor
1
2009
9
0.080
Why?
Chest Pain
1
2009
42
0.080
Why?
Sarcoidosis
1
2010
73
0.080
Why?
Cell Adhesion
1
2010
429
0.080
Why?
Endosonography
1
2010
100
0.080
Why?
Practice Guidelines as Topic
3
2025
1067
0.080
Why?
Tuberculosis
1
2010
123
0.080
Why?
Opioid-Related Disorders
1
2012
199
0.080
Why?
Minimally Invasive Surgical Procedures
1
2011
261
0.080
Why?
Enzyme-Linked Immunosorbent Assay
1
2010
375
0.080
Why?
Mediastinal Neoplasms
2
2005
45
0.080
Why?
RNA, Messenger
2
2013
2034
0.070
Why?
MicroRNAs
2
2011
570
0.070
Why?
Length of Stay
2
2020
761
0.070
Why?
Wound Healing
1
2010
365
0.070
Why?
Microwaves
1
2008
36
0.070
Why?
Radiation Oncologists
2
2018
15
0.070
Why?
Chest Tubes
2
2020
24
0.070
Why?
Analgesics, Opioid
1
2012
458
0.070
Why?
Vascular Endothelial Growth Factor A
1
2009
409
0.070
Why?
NF-kappa B
1
2011
469
0.070
Why?
DNA, Viral
2
1998
265
0.070
Why?
Sex Factors
1
2011
1085
0.070
Why?
Receptor, IGF Type 1
2
1998
45
0.070
Why?
Neovascularization, Pathologic
1
2009
355
0.070
Why?
Diagnostic Imaging
1
2011
478
0.070
Why?
Gene Expression Profiling
2
2010
1473
0.070
Why?
Pulmonary Ventilation
1
2006
33
0.070
Why?
Disease-Free Survival
2
2011
1174
0.070
Why?
Sialoglycoproteins
1
2006
31
0.060
Why?
Carbonic Anhydrases
1
2006
15
0.060
Why?
Sex Distribution
1
2006
170
0.060
Why?
Cognition
1
2011
593
0.060
Why?
Mediastinoscopy
1
2005
5
0.060
Why?
History, 21st Century
2
2017
186
0.060
Why?
Peritoneal Neoplasms
2
1998
183
0.060
Why?
Thoracic Injuries
1
2006
38
0.060
Why?
California
1
2006
152
0.060
Why?
Hemangioendothelioma, Epithelioid
1
2005
9
0.060
Why?
Radiotherapy Dosage
1
2006
471
0.060
Why?
Esophagoplasty
1
2005
10
0.060
Why?
Anesthetics
1
2005
53
0.060
Why?
Blood Loss, Surgical
1
2005
117
0.060
Why?
Risk
1
2006
658
0.060
Why?
Eligibility Determination
1
2024
36
0.060
Why?
Antigens, Neoplasm
1
2006
342
0.060
Why?
Frail Elderly
1
2024
85
0.050
Why?
Incidence
2
2022
1601
0.050
Why?
Adolescent
3
2021
9441
0.050
Why?
Postoperative Care
1
2024
235
0.050
Why?
Elective Surgical Procedures
1
2024
132
0.050
Why?
DNA Helicases
1
2023
85
0.050
Why?
Preoperative Care
1
2005
403
0.050
Why?
Radiotherapy
1
2024
322
0.050
Why?
Proto-Oncogene Proteins c-ret
1
2022
22
0.050
Why?
Work-Life Balance
1
2022
6
0.050
Why?
Asthma
1
2009
998
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2023
316
0.050
Why?
Transfection
3
2011
910
0.050
Why?
Leukocytes
1
2022
210
0.050
Why?
Cross Reactions
1
2021
109
0.050
Why?
Oxygen
1
2006
755
0.040
Why?
Hospital Mortality
1
2003
435
0.040
Why?
Clinical Competence
2
2020
801
0.040
Why?
Antigens, Viral
1
2021
146
0.040
Why?
Immunity, Humoral
1
2021
66
0.040
Why?
Epitopes
1
2021
255
0.040
Why?
Bioethics
1
2020
35
0.040
Why?
Survivors
1
2021
193
0.040
Why?
Risk Management
1
2020
43
0.040
Why?
Etoposide
1
2020
204
0.040
Why?
Bias
1
2020
136
0.040
Why?
Child
2
2022
7291
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2023
494
0.040
Why?
Margins of Excision
1
2019
42
0.040
Why?
Phosphoproteins
1
2021
264
0.040
Why?
Asbestosis
2
1998
5
0.040
Why?
Interdisciplinary Communication
1
2020
130
0.040
Why?
Living Donors
1
2022
340
0.040
Why?
Sputum
1
2018
35
0.040
Why?
Infection Control
1
2020
125
0.040
Why?
Tissue Donors
1
2022
519
0.040
Why?
Electrocardiography
1
2021
498
0.040
Why?
Bronchoalveolar Lavage Fluid
1
2018
128
0.040
Why?
Tumor Virus Infections
1
1998
83
0.040
Why?
Oligonucleotides, Antisense
1
1998
67
0.040
Why?
Self Report
1
2019
302
0.040
Why?
Regulatory Sequences, Nucleic Acid
1
1998
158
0.040
Why?
RNA, Ribosomal, 16S
1
2018
255
0.040
Why?
Heart
1
2021
581
0.040
Why?
Genomics
1
2023
804
0.040
Why?
Pilot Projects
2
2012
890
0.030
Why?
Liver
1
2022
1227
0.030
Why?
RNA, Antisense
1
1996
15
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
169
0.030
Why?
Sensitivity and Specificity
2
2012
2021
0.030
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1996
18
0.030
Why?
Feasibility Studies
2
1996
793
0.030
Why?
Protein-Tyrosine Kinases
1
2018
307
0.030
Why?
Comorbidity
1
2020
966
0.030
Why?
Proto-Oncogene Proteins c-met
1
2018
200
0.030
Why?
B-Lymphocytes
1
2021
744
0.030
Why?
Receptor, ErbB-2
1
2018
255
0.030
Why?
Anniversaries and Special Events
1
2016
15
0.030
Why?
Quality of Life
1
2024
1705
0.030
Why?
Heart Ventricles
1
2021
792
0.030
Why?
Chromosome Disorders
1
1995
113
0.030
Why?
Radiation Oncology
1
2017
122
0.030
Why?
Papillomavirus Infections
1
1998
277
0.030
Why?
Base Sequence
2
1996
2330
0.030
Why?
Genes, Tumor Suppressor
1
1995
154
0.030
Why?
Clinical Trials, Phase II as Topic
1
1995
168
0.030
Why?
National Institutes of Health (U.S.)
1
1995
128
0.030
Why?
Clinical Trials, Phase I as Topic
1
1995
152
0.030
Why?
History, 20th Century
1
2016
316
0.030
Why?
Genetic Predisposition to Disease
1
2023
2383
0.030
Why?
Molecular Sequence Data
2
1996
3033
0.030
Why?
Proto-Oncogene Proteins
1
2018
668
0.030
Why?
Chromosome Aberrations
1
1995
384
0.030
Why?
Genetic Testing
1
2018
546
0.030
Why?
Immunohistochemistry
1
2018
1807
0.030
Why?
DNA Damage
1
1995
375
0.030
Why?
Immunoenzyme Techniques
1
2013
303
0.030
Why?
Fluorescent Antibody Technique
1
2013
324
0.030
Why?
Cricetinae
3
1998
560
0.030
Why?
Genetic Therapy
1
1995
376
0.030
Why?
Pleural Effusion, Malignant
1
2012
16
0.030
Why?
Tumor Necrosis Factor-alpha
1
1996
706
0.030
Why?
Pleural Effusion
1
2012
47
0.030
Why?
Reactive Oxygen Species
1
1995
496
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
288
0.020
Why?
Fear
1
2012
80
0.020
Why?
Self Concept
1
2012
135
0.020
Why?
RNA, Small Interfering
1
2013
557
0.020
Why?
Recurrence
1
2014
1173
0.020
Why?
Thoracoscopes
1
2011
2
0.020
Why?
Radiography, Thoracic
1
2013
329
0.020
Why?
Surgical Staplers
1
2011
11
0.020
Why?
Taxoids
1
2011
125
0.020
Why?
Dissection
1
2011
44
0.020
Why?
Computer Graphics
1
2011
100
0.020
Why?
Community-Based Participatory Research
1
2010
37
0.020
Why?
Motor Skills
1
2011
79
0.020
Why?
Patient Positioning
1
2011
66
0.020
Why?
Carboplatin
1
2011
325
0.020
Why?
Mediastinum
1
2010
48
0.020
Why?
Multivariate Analysis
1
2012
982
0.020
Why?
Affect
1
2012
390
0.020
Why?
Biopsy, Needle
1
2010
233
0.020
Why?
Down-Regulation
1
2011
521
0.020
Why?
Longitudinal Studies
1
2012
1102
0.020
Why?
Empyema
1
2008
9
0.020
Why?
Cells, Cultured
1
2013
2893
0.020
Why?
Depression
1
2012
518
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2006
1302
0.020
Why?
Insulin-Like Growth Factor I
2
1998
115
0.020
Why?
Plasmids
2
1998
292
0.020
Why?
Carbonic Anhydrase IX
1
2006
11
0.020
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.020
Why?
Regression Analysis
1
2007
592
0.020
Why?
Age Factors
1
2010
1878
0.020
Why?
Lymphatic Diseases
1
2005
36
0.020
Why?
Tracheal Diseases
1
2005
14
0.020
Why?
Polymerase Chain Reaction
2
1998
925
0.020
Why?
Predictive Value of Tests
1
2010
1750
0.010
Why?
Animals
4
1998
27852
0.010
Why?
Reproducibility of Results
1
2010
2788
0.010
Why?
Lymphoma, Non-Hodgkin
1
2005
267
0.010
Why?
Disease Progression
1
2007
1499
0.010
Why?
Gene Expression Regulation, Viral
1
1998
93
0.010
Why?
HSP70 Heat-Shock Proteins
1
1998
115
0.010
Why?
Virus Replication
1
1998
328
0.010
Why?
Oxygenators
1
1996
3
0.010
Why?
Sarcoma, Ewing
1
1996
42
0.010
Why?
Cardiac Output
1
1996
154
0.010
Why?
Carcinoma, Adenoid Cystic
1
1996
42
0.010
Why?
Hyperthermia, Induced
1
1996
74
0.010
Why?
Safety
1
1996
144
0.010
Why?
Cell Transformation, Neoplastic
1
1998
458
0.010
Why?
Cell Division
1
1996
692
0.010
Why?
Sarcoma
1
1996
217
0.010
Why?
Interferon-gamma
1
1996
449
0.010
Why?
Remission Induction
1
1996
758
0.010
Why?
Pulmonary Artery
1
1996
326
0.010
Why?
Carcinoma, Renal Cell
1
1996
333
0.010
Why?
Blood Pressure
1
1996
908
0.010
Why?
Melanoma
1
1996
477
0.010
Why?
Transcription, Genetic
1
1996
1164
0.010
Why?
Rats
1
1996
4060
0.010
Why?
Donington's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (425)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_